The	O
patient	O
was	O
continued	O
on	O
Ancef	B-drug
2	O
g	O
IV	O
via	O
PICC	B-treatment
line	I-treatment
and	O
home	O
health	O
administration	O
of	O
IV	O
antibiotics	B-drug
.	O